Michael Andreef

891 citations
17 papers · 698 indexed · h-index 10
Topics
Acute Myeloid Leukemia Research (10 papers)Chronic Myeloid Leukemia Treatments (4 papers)Multiple Myeloma Research and Treatments (3 papers)

In The Last Decade

Michael Andreef

17 papers receiving 687 citations

Peers

Michael Andreef
Comparison fields: 5 of 66
  • Hematology 342
  • Molecular Biology 316
  • Cancer Research 143
  • Genetics 133
  • Oncology 130
Replace Carla B. Ripamonti with:
Carla B. Ripamonti Italy
Ricardo Parrondo United States
Bertil Uggla Sweden
Anne-Marie O’Farrell United States
Maria Kleppe United States
Eri Kawata Japan
Brandon McMahon United States
Bruno A. Cardoso Portugal
J Lyons Germany
Timothy J. Hoy United Kingdom
Michael Andreef relative to Carla B. Ripamonti Italy Carla B. Ripamonti's profile →
Citations per field
00.5×1.5×2.1×
Carla B. Ripamonti · 1×
Citations per year

Countries citing papers authored by Michael Andreef

Since Specialization
Citations

This map shows the geographic impact of Michael Andreef's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Andreef with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Andreef more than expected).

Fields of papers citing papers by Michael Andreef

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Andreef. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Andreef. The network helps show where Michael Andreef may publish in the future.

Co-authorship network of co-authors of Michael Andreef

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Andreef. A scholar is included among the top collaborators of Michael Andreef based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Andreef. Michael Andreef is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 190
2 14
3 3
4 2
5 91
6 3
7 1
8 3
9 45
10 9
11 23
12 73
13 2
14 17
15 16
16 4
17 202

About Michael Andreef

Michael Andreef is a scholar working on Hematology, Genetics and Emergency Medicine, having authored 17 papers that have together received 698 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Hematology (342 citations), Genetics (133 citations) and Cancer Research (143 citations). Michael Andreef has collaborated with scholars based in United States, Italy and Hungary. Frequent co-authors include Hagop M. Kantarjian, Jörge E. Cortes, Farhad Ravandi, Marina Konopleva, Brian H. Mayall, Avery A. Sandberg, Robert C. Leif, J. Schumann, Wolfgang Hiddemann and Barthel Barlogie. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026